Barbarakis M S, Qaisi W G, Daunert S, Bachas L G
Department of Chemistry, University of Kentucky, Lexington 40506-0055.
Anal Chem. 1993 Feb 15;65(4):457-60. doi: 10.1021/ac00052a024.
The inhibition of highly biotinylated enzymes by avidin and streptavidin has been used in the development of homogeneous assays for biotin and other analytes. Usually, this inhibition occurs in a similar fashion for both avidin and streptavidin. Specifically, the curves that relate the inhibition of the enzymatic activity with the concentration of avidin or streptavidin have a sigmoidal shape; I.e., the inhibition of the enzyme-biotin conjugates increases gradually with increasing amounts of avidin or streptavidin and arrives at a plateau at high binding protein concentrations. However, when these two biotin-specific binding proteins interact with biotinylated glucose oxidase a significant difference in their inhibitory action is observed. In particular, the inhibition curves have a sigmoidal shape for streptavidin, while those for avidin exhibit a maximum ("hook") at low avidin concentrations. This difference in the reactivity of the two proteins with biotinylated enzymes influences both the shape of the dose-response curve and the detection limits of homogeneous enzyme-linked competitive binding assays for biotin.
抗生物素蛋白和链霉抗生物素蛋白对高度生物素化酶的抑制作用已被用于开发生物素和其他分析物的均相分析方法。通常,抗生物素蛋白和链霉抗生物素蛋白的这种抑制作用以类似方式发生。具体而言,将酶活性抑制与抗生物素蛋白或链霉抗生物素蛋白浓度相关联的曲线呈S形;即,酶 - 生物素缀合物的抑制作用随着抗生物素蛋白或链霉抗生物素蛋白量的增加而逐渐增加,并在高结合蛋白浓度下达到平稳期。然而,当这两种生物素特异性结合蛋白与生物素化葡萄糖氧化酶相互作用时,观察到它们的抑制作用存在显著差异。特别是,链霉抗生物素蛋白的抑制曲线呈S形,而抗生物素蛋白的抑制曲线在低抗生物素蛋白浓度下出现最大值(“钩状”)。这两种蛋白质与生物素化酶反应性的差异既影响剂量反应曲线的形状,也影响生物素均相酶联竞争结合分析的检测限。